Several studies have reported that metformin can reduce the risk of hepatocellular carcinoma (HCC) in diabetes patients. However. the direct anti-HCC effects of metformin have hardly been studied in patients. but have been extensively investigated in animal models of HCC. https://www.sahmbuffy.com/product-category/quickstrikes/